Loading...

ADC Therapeutics SA (NYSE:ADCT)

7.89 USD +1.01 USD ( +14.68% )
Watchlist Manager
ADC Therapeutics SA
NYSE:ADCT
Watchlist

EV/IC
Enterprise Value to IC

The Enterprise Value to Invested Capital (EV/IC) ratio is a valuation multiple that measures the dollars in Enterprise Value for each dollar of capital invested by shareholders and lenders.

EV/IC
=
Enterprise Value
/
Invested Capital
Current EV/IC
ADCT
3.5
Median EV/IC
ADCT
29.7
Industry EV/IC
Biotechnology
5.9

EV/IC History

Statistics
Enterprise Value to IC

1 Year 3 Years 5 Years
Average 14 67.1 40.7
Median 15.2 29.7 10
Min 2.8 N/A N/A
Max 25.3 170.4 170.4

History Chart
Enterprise Value to IC

EV/IC Forward Multiples

Forward EV/IC multiple is a version of the EV/IC ratio that uses forecasted invested capital for the EV/IC calculation. 1-Year, 2-Years, and 3-Years forwards use invested capital forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/IC
N/A
2-Years Forward
EV/IC
N/A
3-Years Forward
EV/IC
N/A

EV/IC Across Competitors

ADCT Competitors
ADC Therapeutics SA Competitors

Country Company Market Cap EV/IC
CH
ADC Therapeutics SA
NYSE:ADCT
606M USD 3.5
US
Abbvie Inc
NYSE:ABBV
269B USD 2.4
US
Amgen Inc
NASDAQ:AMGN
131B USD 3
AU
CSL Ltd
ASX:CSL
128B AUD 5.7
US
Gilead Sciences Inc
NASDAQ:GILD
79.2B USD 1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
74.8B USD 11.5

Relative Valuation Report

View full relative valuation report for ADC Therapeutics SA, which takes into account all ADCT`s valuation multiples.

See Also

Similar Stocks